TY - CHAP M1 - Book, Section TI - Antihyperlipidemic Drugs A1 - Jobst, Erin E. A1 - Panus, Peter C. A1 - Kruidering-Hall, Marieke Y1 - 2020 N1 - T2 - Pharmacology for the Physical Therapist, 2e AB - CASE STUDYP.E. is a 43-year-old Hispanic man employed on an assembly line at an automotive plant. Four weeks ago, he was involved in an industrial accident in which he experienced muscular strains to his lower extremities and low back. He was evaluated at the onsite clinic, placed on light duty, and referred to an outpatient physical therapy clinic. P.E. has a body mass index of 27 kg/m2, hypertriglyceridemia, and high plasma low-density lipoprotein (LDL) cholesterol. He is taking gemfibrozil and niacin to improve his lipid profile. During his first visit to the outpatient physical therapist 3 weeks ago, he complained of diffuse muscle and joint pain in both legs and his back. He also stated that his legs felt weak. During the first week of rehabilitation, supportive therapy for pain relief only slightly improved his ability to function in light duty work. Last week, he began a work-hardening program to enable him to return to full-time regular work. During the program, he complained that his previous pain and muscle weakness increased. The physical therapist initially assumed that his pain might be related to initiating exercises included in the work-hardening program and noted this in the chart as suspected delayed onset muscle soreness (DOMS). P.E. continued performing the work-hardening program and the therapist reevaluated his functional status the following week. Upon questioning, P.E. denied any changes in his medications since his initial evaluation. He also denied taking over-the-counter medications or dietary supplements. However, he added that he started taking “red yeast rice” approximately 5 weeks ago because he heard that it lowers “bad cholesterol.” When asked why he did not include this on the initial evaluation form, he stated: “the form only asked for medications, and red yeast rice is just a naturally occurring cholesterol-lowering supplement.” SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/11/09 UR - accessphysiotherapy.mhmedical.com/content.aspx?aid=1192817765 ER -